The use of tranexamic acid to reduce blood loss during and after cesarean sectio

Phase 3

Completed

• Conditions: Prevention of Postpartum hemorrhage; Reproductive Health and Childbirth - Childbirth and postnatal care

• Registration Number: ACTRN12612000313831
• Lead Sponsor: Faculty of Medicine,Assiut University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-03-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 700

Inclusion Criteria

All pregnant women with single fetus planned to have elective cesarean section at greater than 36wks gestation

Exclusion Criteria

1. History of medical disorders.
2. Preclampsia.
3. Antepartum hemorrhage.
3. History of thromboembolic disorders.
4. Polyhydramnios.
5. Macrosomia.
6. History of sensitivity to Tranexamic acid.
7. Patients taking anticoagulant therapy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean blood loss (ml) .The quantity of blood loss (mL) during C.S will be measure as follow= (weight of the used surgical towels minus weight of the towels prior to the surgery) + the volume sucked in the suction bottle after placental delivery in mL.<br>Blood loss during transfer of the patient to the postoperative care will be measured by using calibrated plastic drape put under the patients intraoperative. <br>In addition blood loss after the operation will be calculated separately (within 2Hour postpartum) by using a calibrated plastic drape put under the patients, So the patients can use one or two calibrated plastic drape.[Blood loss will be collected during and for two hours after operation]